148 related articles for article (PubMed ID: 15175083)
1. No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma.
Mueller W; Eum JH; Lass U; Paulus W; Sarkar C; Bruck W; von Deimling A
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):304-7. PubMed ID: 15175083
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas.
Zakrzewska M; Wojcik I; Zakrzewski K; Polis L; Grajkowska W; Roszkowski M; Augelli BJ; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2005 Jan; 156(2):179-82. PubMed ID: 15642401
[TBL] [Abstract][Full Text] [Related]
3. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
5. INI1 mutations in meningiomas at a potential hotspot in exon 9.
Schmitz U; Mueller W; Weber M; Sévenet N; Delattre O; von Deimling A
Br J Cancer; 2001 Jan; 84(2):199-201. PubMed ID: 11161377
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of INI1 in sporadic human brain tumors.
Weber M; Stockhammer F; Schmitz U; von Deimling A
Acta Neuropathol; 2001 May; 101(5):479-82. PubMed ID: 11484819
[TBL] [Abstract][Full Text] [Related]
8. Absence of hSNF5/INI1 mutation in human lung cancer.
Manda R; Kohno T; Hamada K; Takenoshita S; Kuwano H; Yokota J
Cancer Lett; 2000 May; 153(1-2):57-61. PubMed ID: 10779630
[TBL] [Abstract][Full Text] [Related]
9. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
10. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
[TBL] [Abstract][Full Text] [Related]
11. Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene.
Kraus JA; Oster C; Sörensen N; Berthold F; Schlegel U; Tonn JC; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 2002 Apr; 28(2):136-41. PubMed ID: 11972800
[TBL] [Abstract][Full Text] [Related]
12. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
[TBL] [Abstract][Full Text] [Related]
13. Atypical teratoid/rhabdoid tumors and choroid plexus tumors: when genetics "surprise" pathology.
Gessi M; Giangaspero F; Pietsch T
Brain Pathol; 2003 Jul; 13(3):409-14. PubMed ID: 12946029
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
[TBL] [Abstract][Full Text] [Related]
15. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.
Versteege I; Sévenet N; Lange J; Rousseau-Merck MF; Ambros P; Handgretinger R; Aurias A; Delattre O
Nature; 1998 Jul; 394(6689):203-6. PubMed ID: 9671307
[TBL] [Abstract][Full Text] [Related]
16. Two single nucleotide polymorphisms of the hSNF5/INI1 gene.
Mine N; Bando K; Utada Y; Nagai H; Araki T; Emi M
J Hum Genet; 1999; 44(5):354-5. PubMed ID: 10496084
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
[TBL] [Abstract][Full Text] [Related]
18. Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis.
Ruland V; Hartung S; Kordes U; Wolff JE; Paulus W; Hasselblatt M
Genes Chromosomes Cancer; 2014 May; 53(5):373-80. PubMed ID: 24478045
[TBL] [Abstract][Full Text] [Related]
19. High-resolution genomic analysis does not qualify atypical plexus papilloma as a separate entity among choroid plexus tumors.
Japp AS; Gessi M; Messing-Jünger M; Denkhaus D; Zur Mühlen A; Wolff JE; Hartung S; Kordes U; Klein-Hitpass L; Pietsch T
J Neuropathol Exp Neurol; 2015 Feb; 74(2):110-20. PubMed ID: 25575132
[TBL] [Abstract][Full Text] [Related]
20. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.
Sévenet N; Sheridan E; Amram D; Schneider P; Handgretinger R; Delattre O
Am J Hum Genet; 1999 Nov; 65(5):1342-8. PubMed ID: 10521299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]